Current Price Status
Stock is Shooting to the Moon
Stock is over-priced on the upper end by the market with the expectation of annual earning growth at 374.85% to match current price.
Stock in booming mode can be traded very volatile, price can swing largely day-to-day. While having big upside potential, the downside risk can be huge if the stock is not meeting the market expectation.
Company is not in Profit
- PHARMA current price is 274.07% above OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
UnderperformedPHARMA past 5-day return lagged behind the Pharmaceuticals industry average return by 6.89%
Below 30-Day AverageCurrent price RM5.05 is below 30-day average RM5.12 by 1.4%
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Recent Weak Revenue Growth
PHARMA posted a weaker revenue growth in the recent quarter than normal average.
Unstable Profit Growth
PHARMA has been experiencing substantial ups and downs on profit growth.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Increasing
Surge in trading volume tends to bring more price volatility in near term.
PHARMA recent daily traded volume is 109.09% higher than past month average.
|Past 30-Day||Past 5-Day|
|11k daily||23k daily|
Price History Chart
Past 30-day Average Price: RM5.12
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Market News & Investor Opinions
Stock Company Profile
Pharmaniaga Bhd. is an investment holding company. It engages in the research & development, manufacturing of generic pharmaceutical products, sales & marketing as well as logistics and distribution of pharmaceutical products & medical equipment. The firm operates through the following segments: Logistics and Distribution, Manufacturing, and Indonesia. The Logistics and Distribution segment engages in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment manufactures pharmaceutical products in Malaysia. The Indonesia segment manufactures and distributes pharmaceutical and medical products in Indonesia. The company was founded on August 21, 1998 and is headquartered in Shah Alam, Malaysia.